Steve Pakola Regenxbio Inc. (RGNX) insider trading activity

RGNX Quotes by TradingView

Steve Pakola is Chief Medical Officer of REGENXBIO Inc.. Currently has a direct ownership of 165,578 shares of RGNX, which is worth approximately $1.23 Million. The most recent transaction as insider was on Aug 01, 2024, when has been sold 58,386 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K
0% 3M change
1259.98% 12M change
Total Value Held $1.23 Million

STEVE PAKOLA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
BUY
Grant, award, or other acquisition
-
58,386 Added 26.07%
165,578 Common Stock
Mar 05 2024
SELL
Open market or private sale
$365,220 $28.36 p/Share
12,878 Reduced 10.73%
107,192 Common Stock
Mar 05 2024
BUY
Exercise of conversion of derivative security
$286,535 $22.25 p/Share
12,878 Added 9.69%
120,070 Common Stock
Jan 03 2024
SELL
Open market or private sale
$299,751 $17.39 p/Share
17,237 Reduced 13.85%
107,192 Common Stock
Jan 02 2024
SELL
Payment of exercise price or tax liability
$186,410 $17.95 p/Share
10,385 Reduced 10.11%
92,378 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
32,051 Added 20.48%
124,429 Common Stock
Jan 03 2023
SELL
Open market or private sale
$69,569 $22.17 p/Share
3,138 Reduced 20.49%
12,175 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$41,663 $22.68 p/Share
1,837 Reduced 10.71%
15,313 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
90,588 Added 46.85%
102,763 Common Stock
Jan 03 2022
SELL
Open market or private sale
$53,932 $33.75 p/Share
1,598 Reduced 16.23%
8,250 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
8,900 Added 34.17%
17,150 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$37,670 $32.7 p/Share
1,152 Reduced 10.47%
9,848 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 50.0%
11,000 Common Stock
SP

Steve Pakola

Chief Medical Officer
Rockville, MD

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGNX